Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients

Am J Nephrol. 1991;11(6):470-4. doi: 10.1159/000168361.

Abstract

Hyperlipidemia poses a risk for cardiovascular disease in both hemodialysis and renal transplantation patients. Although lipid profiles differ between the 2 populations, we evaluated the possibility that both groups have similar abnormalities of lipoprotein(a) [Lp(a)]. Mean serum Lp(a) and standard error of the mean (SEM) in hemodialysis and transplant recipients was 16.6 +/- 4.7 and 18.3 +/- 3.6 mg/dl, respectively, compared with 10.7 +/- 4.1 mg/dl in healthy controls, p less than 0.05. That serum Lp(a) levels are significantly elevated in dialysis and renal transplantation patients suggests at least 1 common pathogenic mechanism for the high incidence of atherosclerosis in both groups.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Arteriosclerosis / epidemiology*
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Female
  • Humans
  • Hyperlipidemias / epidemiology*
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / therapy
  • Kidney Transplantation*
  • Lipoprotein(a)
  • Lipoproteins / blood*
  • Male
  • Plasminogen / antagonists & inhibitors
  • Renal Dialysis*
  • Risk Factors
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Lipoprotein(a)
  • Lipoproteins
  • Triglycerides
  • Plasminogen
  • Cholesterol